MedPage Today (9/6, Walsh) reports that research involving nearly 2,000 individuals published online in the Journal of Clinical Endocrinology and Metabolism suggests that “the use of selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants among women in midlife didn’t lead to a greater rate of bone loss.” Researchers found that, “among women enrolled in the longitudinal Study of Women’s Health Across the Nation, yearly decrease in bone mineral density (BMD) at the lumbar spine averaged 0.63% in new users of SSRIs compared with 0.68% in those not taking antidepressants (P=0.37).” The study also indicated that “among those taking the tricyclic antidepressants, the annual lumbar spine BMD decrease was 0.40% (P=0.16 compared with nonusers).”
Related Links:
— “Antidepressants Have No Effect on Bone Loss, “Nancy Walsh, MedPage Today, September 5, 2013.